Skip to main content
Equibles

HARBOR INVESTMENT ADVISORY, LLC

Position in ALZN — Alzamend Neuro, Inc.

CIK 1468792 LUTHERVILLE, MD
Back to ALZN Full portfolio

Position in ALZN

as of Jun 30, 2026 · filed Jul 7, 2026
Position Value
$1
+$0 QoQ
Shares Held
1
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 12 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALZN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HARBOR INVESTMENT ADVISORY, LLC holds $5,602,456 across 30 Biotechnology names. ALZN ranks #30 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 2,382 $1,485,272
2 ARGX
Argenx SE
 1,157 $1,073,429
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,399 $694,925
4 TECH
BIO-TECHNE Corp
 9,300 $657,045
5 BBIO
BridgeBio Pharma, Inc.
 1,835 $136,670
6 CRSP
CRISPR Therapeutics AG
 2,300 $125,442
7 HALO
Halozyme Therapeutics, Inc.
 1,494 $116,935
8 MDGL
Madrigal Pharmaceuticals, Inc.
 208 $111,685

All Filings in ALZN

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1 1
2026-03-31 $1 1
2025-12-31 $1 1
2025-09-30 $2 1
2025-06-30 $2 1
2025-03-31 $18 20
2024-12-31 $23 20
2024-09-30 $33 20
2024-06-30 $78 200
2024-03-31 $199 200
2023-12-31 $177 200
2023-09-30 $710 3,000
2023-06-30 $1,529 3,000
2023-03-31 $1,274 3,000
2022-12-31 $451 800
2022-09-30 $2,040 1,715
2022-06-30 $1,481 1,715
2022-03-31 $2,109 1,715
2021-12-31 $2,688 1,415
2021-09-30 $2,510 815